Market News & Trends
PolyTherics & TUBE Pharma Form Development Collaboration
PolyTherics Limited and TUBE Pharma GmbH recently announced they are collaborating to produce reagents to link novel cytotoxic drugs developed by TUBE to antibodies using…
Frost & Sullivan: Technological Innovation Widens Global Application of Mass Spectrometry
The global mass spectrometry (MS) market is growing much faster than the high-end analytical instrumentation market. This is a sign that demand is high in…
DPT Laboratories & Confab to Integrate
DPT Laboratories and Confab recently announced the integration of the organizations under the leadership of Paul Johnson, Group President and COO. Both DPT and Confab…
Regeneron & Sanofi Report Positive Top-Line Results
Sanofi and Regeneron Pharmaceuticals, Inc. recently announced that the Phase III ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin…
Stallergenes & DBV Technologies Announce $198-Million Deal
Stallergenes S.A., and DBV Technologies recently announced they have entered into a research and development agreement for the treatment of birch allergy. This collaboration is…
EMD Millipore to be Global Distributor for SmartRNAplex MicroRNA Profiling Assay
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently announced they have entered into an agreement with Firefly BioWorks to be…
Rexahn In-Licenses Novel Oligonucleotide Targeted Drug Delivery Platform
Rexahn Pharmaceuticals, Inc. recently announced it has signed an exclusive license agreement with the Ohio State Innovation Foundation, an affiliate of The Ohio State University,…
Aegis Therapeutics Awarded its First Patent for Non-Invasive Delivery of Protein Drug to CNS
Aegis Therapeutics LLC recently announced it has been awarded its first patent for non-invasive delivery of a protein drug to the central nervous system (CNS).…
North American Drug Delivery Technologies Market Worth $102.2 Billion by 2017
Patent expiry of major blockbuster drugs is a prime concern for pharmaceutical companies, as developing a new chemical entity (NCE) is more expensive and time…
Vetter to Construct New Filling Lines to Expand Capacity
Vetter recently announced it is investing more than $100 million across its production sites in Germany and the United States. Expanding and upgrading its facilities…
Catalent Continues Major Growth Drive With Latest Acquisition Into Emerging Markets
Catalent Pharma Solutions recently announced the acquisition of Relthy Laboratórios in Brazil. Catalent continues to build upon its global leadership position by expanding its operations…
BioDelivery Sciences International Announces NDA Acceptance
BioDelivery Sciences International, Inc. recently announced that its NDA for BUNAVAIL (buprenorphine naloxone buccal film) for the maintenance treatment of opioid dependence has been accepted…
Greek Market to Show Modest Growth; Indian Market to Reach $56 billion
The growing prevalence of chronic diseases and an increasing elderly population will boost the Greek pharmaceutical market, which will increase from approximately $7.8 billion in…
Bright Future Ahead for Biopharmaceutical Contract Manufacturing
Considerable growth opportunities lie ahead for biopharmaceutical contract manufacturing organizations (CMOs). With blockbuster biologics worth over $100 billion due to lose patent protection by 2019,…
Gallus Strengthens Biologics CMO Business With Acquisition
Gallus BioPharmaceuticals, LLC recently announced its acquisition of Laureate Biopharmaceutical Services, Inc., a full-service biologics CMO located in Princeton, NJ. This acquisition doubles Gallus’ process…
Effimune Announces Major Global License Agreement
Effimune recently announced a global option and license agreement with Janssen Biotech, Inc. The collaboration between Effimune, the London Innovation Centre of Johnson & Johnson…
Cambridge Major Laboratories & AAIPharma Services Announce Merger
Cambridge Major Laboratories, Inc. and AAIPharma Services Corp. recently announced their intent to merge to form the premier global supplier of integrated CMC services. Financial…
Hovione Announces Successful Inspection
Hovione's plant in Loures, Portugal, has successfully passed a GMP and Postmarket Approval inspection by FDA. The inspection, carried out by Mrs. Yumi Hiramine, Inspector…
Capsugel Expands Global Manufacturing for Finished Dosage Forms
Capsugel’s Dosage Form Solutions (DFS) business unit unveiled extensive upgrades and expansions to three of its manufacturing facilities in the US and Europe, deepening the…
West Dedicates Second Manufacturing Plant in China
West Pharmaceutical Services, Inc. hosted a dedication ceremony to mark the start-up of its recently completed compression molding plant in the Shanghai Zhangjiang High-Tech Industrial…
